Report overview
The major advantage of Flu RNA Vaccines is that scientist need not to use the live cells for the vaccine preparation as such the RNA can be produced in the laboratory from a DNA template using readily available materials which can be a easy and fast weapon to fight against the new outbreaks and the existing infectious diseases.
This report contains market size and forecasts of Flu RNA Vaccines in global, including the following market information:
Global Flu RNA Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Flu RNA Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Flu RNA Vaccines companies in 2021 (%)
The global Flu RNA Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Replicating mRNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Flu RNA Vaccines include Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., Pfizer, BioNTech and F.Hoffman La Roche Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Flu RNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu RNA Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, by Type, 2021 (%)
Non-Replicating mRNA
In Vivo Self-Replicating mRNA
In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
Others
Global Flu RNA Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospitals
Vaccination Center
Specialized Clinics
Hospital Pharmacy
Others
Global Flu RNA Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flu RNA Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Flu RNA Vaccines revenues share in global market, 2021 (%)
Key companies Flu RNA Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Flu RNA Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Pasteur Inc.
AstraZeneca
CSL Ltd.
Abbott
GlaxoSmithKline Plc.
Serum Institute of India Pvt. Ltd.
Pfizer
BioNTech
F.Hoffman La Roche Ltd
Novartis
Sinnovac Biotech Ltd
Moderna Therapeutics
CureVac
